Zevra Therapeutics, Inc.ZVRANASDAQ
Loading
Operating Income ScalingExpanding
Percentile Rank92
Studio
Year-over-Year Change

Profit from core business operations before interest and taxes

Latest
$-4.23M
↑ 87% vs avg
Percentile
P92
Near historical high
Streak
1 yr
Consecutive growthExpanding
Average
$-32.84M
Historical baseline
PeriodValueYoY Change
2025$-4.23M+95.1%
2024$-87.00M-75.4%
2023$-49.60M-16.5%
2022$-42.56M-650.7%
2021$7.73M+237.8%
2020$-5.61M+72.4%
2019$-20.34M+63.6%
2018$-55.90M-67.5%
2017$-33.37M+11.0%
2016$-37.48M-